Emily Limerick, MD

Dr. Emily Limerick is a staff clinician in NHLBI working in the Laboratory of Early Sickle Mortality Prevention. She completed her pediatric hematology/oncology fellowship in the combined Johns Hopkins- NIH training program. Dr. Limerick's research focuses on haploidentical stem cell transplantation for sickle cell disease as well as biomarkers of organ function in sickle cell disease, specifically sickle nephropathy with a burgeoning interest in sickle cardiomyopathy. She is the principal investigator of a study exploring markers of sickle nephropathy as well as an allogeneic transplant protocol for patients who have failed a prior transplant. Dr. Limerick is a past participant in the American Society of Hematology’s Clinical Research Training Institute. She earned her Masters in Clinical Research through the combined Duke-NIH Clinical Research Training Program; her thesis work explored renal function in patients with sickle cell disease after stem cell transplantation.

Publications

Kidney function after nonmyeloablative hematopoietic cell transplant for sickle cell disease

Lipid Levels Increase to the Normal Range After Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease

Improvement in Cardiac Morphology Demonstrated by Cardiac Magnetic Resonance Imaging and Echocardiography after Haploidentical Hematopoietic Cell Transplantation in Adults with Sickle Cell Disease

Across the Myeloablative Spectrum: Hematopoietic Cell Transplant Conditioning Regimens for Pediatric Patients with Sickle Cell Disease

Choice of Donor Source and Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Sickle Cell Disease